Cargando…

COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry

INTRODUCTION: Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) registry to determine whether cancer patients are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rüthrich, Maria Madeleine, Giessen-Jung, C., Borgmann, S., Classen, A. Y., Dolff, S., Grüner, B., Hanses, F., Isberner, N., Köhler, P., Lanznaster, J., Merle, U., Nadalin, S., Piepel, C., Schneider, J., Schons, M., Strauss, R., Tometten, L., Vehreschild, J. J., von Lilienfeld-Toal, M., Beutel, G., Wille, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648543/ https://www.ncbi.nlm.nih.gov/pubmed/33159569 http://dx.doi.org/10.1007/s00277-020-04328-4

Ejemplares similares

COVID-19 in patients with cirrhosis: insights from the multinational LEOSS registry
por: Brozat, Jonathan Frederik, et al.
Publicado: (2022)

First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”
por: Jakob, Carolin E. M., et al.
Publicado: (2020)

Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
por: Huber, Meret K., et al.
Publicado: (2021)

Hospitalized patients dying with SARS-CoV-2 infection—An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry
por: Raichle, Claudia, et al.
Publicado: (2022)

COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry
por: Brozat, Jonathan F., et al.
Publicado: (2022)

Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)
por: Kleineberg, Nina N., et al.
Publicado: (2021)

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort
por: Schons, Maximilian J., et al.
Publicado: (2021)

Gastrointestinal bleeding and endoscopic findings in critically and non‐critically ill patients with corona virus disease 2019 (COVID‐19): Results from Lean European Open Survey on SARS‐CoV‐2 (LEOSS) and COKA registries
por: Zellmer, Stephan, et al.
Publicado: (2021)

Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort
por: Schons, Maximilian J., et al.
Publicado: (2021)

Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry
por: Stefan, Norbert, et al.
Publicado: (2022)

Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry
por: Cremer, Sebastian, et al.
Publicado: (2020)

Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease
por: Pilgram, Lisa, et al.
Publicado: (2021)

Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort
por: Freise, Noemi F., et al.
Publicado: (2022)

Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning
por: Jakob, Carolin E. M., et al.
Publicado: (2021)

Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry
por: Schmidt-Hellerau, Kirsten, et al.
Publicado: (2023)

Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany
por: Koppe, Uwe, et al.
Publicado: (2023)

Infektionsmanagement in der Hämatologie und Onkologie: Verantwortungsvoller Einsatz von Antiinfektiva
por: Classen, Annika Yanina, et al.
Publicado: (2022)

Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study
por: Pilgram, Lisa, et al.
Publicado: (2023)

Development and validation of a simplified risk score for the prediction of critical COVID‐19 illness in newly diagnosed patients
por: Werfel, Stanislas, et al.
Publicado: (2021)

Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences
por: Rüthrich, Maria Madeleine, et al.
Publicado: (2022)

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease
por: Cremer, Sebastian, et al.
Publicado: (2021)

Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)
por: Kochanek, Matthias, et al.
Publicado: (2019)

Corrigendum to “Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases”[Artificial Intelligence in Life Sciences] 1(2021), 100020
por: Linden, Thomas, et al.
Publicado: (2022)

Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases
por: Linden, Thomas, et al.
Publicado: (2021)

Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities
por: Rieder, Marina, et al.
Publicado: (2021)

Specific Risk Factors for Fatal Outcome in Critically Ill COVID-19 Patients: Results from a European Multicenter Study
por: Meintrup, David, et al.
Publicado: (2021)

Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases
por: von Lilienfeld-Toal, Marie, et al.
Publicado: (2020)

Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathways
por: Bartenschlager, Christina C., et al.
Publicado: (2023)

Detection of community‐acquired respiratory viruses in allogeneic stem‐cell transplant recipients and controls—A prospective cohort study
por: Rachow, Tobias, et al.
Publicado: (2020)

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Giesen, Nicola, et al.
Publicado: (2020)

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy
por: Giesen, Nicola, et al.
Publicado: (2021)

Entwicklung und Validierung potenzieller Strukturindikatoren zur Evaluierung des klinisch-infektiologischen Versorgungsangebots in deutschen Krankenhäusern während der COVID-19-Pandemie
por: Tscharntke, Lene, et al.
Publicado: (2023)

A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice
por: Hanses, Frank, et al.
Publicado: (2022)

COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity
por: Heissig, Beate, et al.
Publicado: (2022)

Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature
por: Feldmann, Georg, et al.
Publicado: (2013)

Impfung gegen SARS-CoV-2 bei Krebspatienten
por: von Lilienfeld-Toal, Marie, et al.
Publicado: (2021)

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
por: Classen, Annika Y., et al.
Publicado: (2021)

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
por: Neumann, S., et al.
Publicado: (2013)

Pneumonien bei immunsupprimierten Patienten
por: Moeser, A., et al.
Publicado: (2018)

Age and Comorbidity Burden of Patients Critically Ill with COVID-19 Affect Both Access to and Outcome of Ventilation Therapy in Intensive Care Units
por: de Hesselle, Marie Louise, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lj2k6g4fidhbgpmu9n6dc8qhn4